Journals / Anadolu Kardiyoloji Dergisi / 2007 / Cilt: 7 - Sayı: 2

Koroner baypas operasyonu yapılan hastalarda kan şekeri düzeyinin ameliyat mortalite/morbidite üzerine etkisi ve diyabetik hastaların koronerateroskleroz dağılımı; Tek merkezin deneyimi

Coronary atherosclerosis distribution and the effect of blood glucose level on operative mortality/morbidity in diabetic patients undergoing coronary artery bypass grafting surgery; a single center experience

Pages
158–163
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Operation time and the duration of cardiopulmonary bypass and cross clamp were significantly longer in patients with high blood glucose levels (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The study aim was to investigate the effect of blood glucose level on atherosclerotic lesion distribution and the contribution to theoperative mortality/morbidity in diabetic patients who underwent coronary artery bypass grafting (CABG).
📊
Key Findings & Data:Methods: Between 1986-2003, a total of 2095 patients with diabetes mellitus underwent CABG.
💡
Conclusion & Impact:Operation time and the duration of cardiopulmonary bypass and cross clamp were significantly longer in patients with high blood glucose levels (p
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The study aim was to investigate the effect of blood glucose level on atherosclerotic lesion distribution and the contribution to theoperative mortality/morbidity in diabetic patients who underwent coronary artery bypass grafting (CABG). Methods: Between 1986-2003, a total of 2095 patients with diabetes mellitus underwent CABG. The analysis was carried out retrospectively from the clinical records. The patients were divided into four groups according to the blood glucose levels that were obtained when they first applied to hospital; Group 1 (492 patients with blood glucose 250 mg/dl). “One way ANOVA” test was used for the statistical analysis of continuous variables and Chi-square test was used for analyzing the categorical variables. Results: Emergent operation rate due to acute ischemia gradually increased from Group 1 to Group 4 and reached 6.6% in Group 4 (p=0.005). Operation time and the duration of cardiopulmonary bypass and cross clamp were significantly longer in patients with high blood glucose levels (p

Özet

Amaç: Koroner baypas operasyonu planlanan hastalarda kan şekeri düzeyinin diyabetik hastalarda koroner aterosklerotik lezyon dağılımının araştırılması planlanmıştır.Yöntemler: 1986-2003 yılları arasında koroner baypas yapılan diyabetes mellituslu 2095 hasta çalışmaya dahil edilmiştir. Araştırma retrospektif olarak hasta kayıtları üzerinden yapılmıştır. Hastalar, hastaneye ilk başvurdukları anda yapılan tetkiklerindeki kan glükoz seviyelerine göre 4 gruba ayrılmıştır; Grup 1 (492 hasta, kan glükoz seviyesi250 mg/dl). Devamlı değişkenler için “one way ANOVA”, kategorik değişkenler için Ki-kare testi kullanılmıştır. Bulgular: Akut iskemiye bağlı acil operasyon gruplar arasında birden dörde doğru giderek artmakta ve Grup 4’de % 6.6’ya ulaşmaktadır (p=0.005). Operasyon, kardiyopulmoner baypas ve kros-klemp süreleri kan glükoz seviyeleri yüksek olan hastalarda anlamlı derecede uzundur (p

🔖

Cite This Article

TÜTÜN, U., TEMÜRTÜRKAN, M., KATIRCIOĞLU, S., BUDAK, B., SEREN, M., PARLAR, A. İ., ULUS, A., ÇİÇEKÇİOĞLU, F. (2022). Koroner baypas operasyonu yapılan hastalarda kan şekeri düzeyinin ameliyat mortalite/morbidite üzerine etkisi ve diyabetik hastaların koronerateroskleroz dağılımı; Tek merkezin deneyimi. Anadolu Kardiyoloji Dergisi, Cilt: 7 - Sayı: 2, 158–163. https://ajindex.com/articles/437145

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Szabo Z, Håkanson E, Svedjeholm R. Early postoperative outcome and medium-term survival in 540 diabetic and 2239 nondiabetic patients undergoing CABG. Ann Thorac Surg 2002;74:712–9
  2. Herlitz J, Sjöland H, Haglid M, Karlson BW, Caidahl K, Wiklund I, et al. Impact of a history of diabetes mellitus on quality of life after coronary artery bypass grafting. Eur J of Cardiothorac Surg 1997; 12: 853-61
  3. Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Jones EL,et al. Influence of DM on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 1999; 67: 1045–52 4. Fish LH, Weaver TW, Moore AL, Steel LG. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. Am J Card 2003;92: 74-6
  4. Mathew V, Holmes DR. (Data from the BARI registry and the Duke database) Outcomes in diabetics undergoing revascularization the long and the short of it. J Am Coll Cardiol 2002; 40: 424-7
  5. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004; 10 (Suppl 2): 21-33
  6. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-83
  7. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults-The Evidence Report: National Institutes of Health. Obes Res 1998; (Suppl 2):51S-209S 9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel II). JAMA 1993; 269: 3015-23
  8. Herlitz J, Malmberg K. How to improve the cardiac prognosis for diabetes. Diabetes Care 1992; 22 (Suppl 2): B89-96
  9. Fein F, Scheuer J. Heart disease in diabetes mellitus: theory and practice. 4th ed. New York: Elsevier Science Inc; 1990
  10. Nashef SA, Roques F, Michel P, Cortina J, Faichney A, Gams E, et al. Coronary surgery in Europe: comparison of the national subsets of the European system for cardiac operative risk evaluation database. Eur J Cardiothorac Surg 2000; 17: 396-9
  11. Feid FS. Heart disease in diabetics. Cardiovasc Rev Rep 1982; 3: 877-93
  12. Waller B, Palumbo P, Roberts W. Status of the coronary ar